EXASCAUTIOUS

EXAS EV/EBITDA Analysis

169.2x

Higher than 100% of Healthcare sector peers

Updated 2555h ago·SEC filings & market data

Key Takeaway

EXAS (EXAS) has a EV/EBITDA of 169.2x as of May 2026.

Sector Performance

100th percentile

EXAS

169.2x

Sector Median

16.1x

Sector Avg

29.1x

📊

Deep Analysis

EXAS (EXAS) has a EV/EBITDA of 169.2x as of May 2026.

This places EXAS in the 100th percentile of the Healthcare sector, which has a median EV/EBITDA of 16.1x and a sector average of 29.1x. EXAS's EV/EBITDA is 952.4% above the sector median, a significant divergence that warrants closer examination. In context: A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

Frequently Asked Questions

What does the EV/EBITDA tell investors about EXAS?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does EXAS's EV/EBITDA compare to its sector?

EXAS's EV/EBITDA of 169.2x compares to a Healthcare sector median of 16.1x, placing it in the 100th percentile.

Who are EXAS's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: CAH (15.2x), RVTY (17.0x), DGX (14.3x), AMGN (14.0x), ALGN (13.5x).

📚

Learn More About EV/EBITDA

EV/EBITDA Explained: The Valuation Metric Pro Investors Actually Use

Learn what EV/EBITDA is, why it beats P/E for capital-heavy companies, typical sector ranges, and key limitations every serious investor should know.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.